Essentials im atopischen Ekzem-Management

Zusammenfassung

Das insbesondere im Kindesalter sehr häufige atopische Ekzem benötigt eine stadiengerechte Ekzembehandlung unter besonderer Berücksichtigung der Basistherapie. Für die antientzündliche läsionale Behandlung stellen topische Steroide der 4. Generation sowie topische Calcineurin-Inhibitoren die Substanzen der Wahl dar. Das konsequente Meiden irritativer Faktoren sowie nach entsprechender Testung allergischer Provokationsfaktoren flankiert die therapeutischen Maßnahmen.

Abstract

Atopic eczema is a frequent chronic disease manifestating especially in early childhood. A disease-related anti-inflammatory treatment in combination with adjuvant basic therapy is mandatory. Topical 4^th generation steroids and topical calcineurin-inhibitors are the anti-inflammatory substances of choice. The consequent avoidance of irritatative and individual allergic provocation factors based on appropiate testing support active dermatological treatment.

Literatur

• 1 Abeck D. Topische Calcineurin-Inhibitoren bei atopischem Ekzem - Contra.  DMW. 2006;  131 1615
• 2 http://www.atopa.de/atopa_studie.htm
• 3 Baker B S. The role of microorganisms in atopic dermatitis.  Clin Exp Dermatol. 2006;  144 1-9
• 4 Byremo S, Rod G, Carlsen K H. Effect of climate change in children with atopic eczema.  Allergy. 2006;  61 1403-1410
• 5 Gauger A, Fischer S, Mempel M, Schaefer T, Foelster-Holst R, Abeck D, Ring J. Efficacy and functionality of silver-coated textiles in patients with atopic dermatitis.  J Eur Acad Dermatol Venereol. 2006;  20 534-541
• 6 Heine G, Schnuch A, Uter W, Worm M. Type IV-sensitization profile of individuals with atopic eczema: results from the Information Network of Departements of Dermatology (IVDK) and the German Contact Dermatitis Research Group (DKG).  Allergy. 2006;  61 611-616
• 7 Illi S, von Mutius E, Lau S, Nickel R, Gruber C, Niggemann B, Wahn U. The natural course of atopic dermatitis from birth to age 7 years and the association with asthma.  J Allergy Clin Immunol. 2004;  113 925-931
• 8 Langer K, Breuer K, Kapp A, Werfel T. Staphylococcus aureus-derived enterotoxins enhance house dust mite-induced patch test reactions in atopic dermatitis.  Exp Dermatol. 2007;  16 124-129
• 9 Senti G, Steinmann L S, Fischer B, Kurmann R, Storni T, Johansen P, Schmid-Grendelmeier P, Wüthrich B, Kundig T M. Antimicrobial silk clothing in the treatment of atopic dermatitis proves comparable to topical steroid treatment.  Dermatology. 2006;  213 228-233
• 10 Simpson E L. Atopic dermatitis prevention.  Dermatol Ther. 2006;  19 108-117
• 11 Werfel T, Bruer K, Rueff F, Przybilla B, Worm M, Grewe M, Ruzicka T, Brehler R, Wolf H, Schnitker J, Kapp A. Usefulness of specific immunotherapy in patients with atopic dermatitis and allergic sensitisation to house dust mites: a multi-centre, randomised, dose-response study.  Allergy. 2006;  61 202-205
• 12 Williams J R, Burr M L, Williams H C. Factors influencing atopic dermatitis - a questionnaire survey of schoolchildren’s perceptions.  Br J Dermatol. 2004;  150 1154-1161
• 13 Wohlrab J, Jost G, Abeck D. Antiseptic efficacy of a low-dosed topical triclosan/chlorhexidine combination therapy in atopic dermatitis.  Skin Pharmacol Physiol. 2006;  20 71-76
• 14 Wollenberg A. Topische Calcineurin-Inhibitoren bei atopischem Ekzem - Pro.  DMW. 2006;  131 1614